A Randomized, Open-label, Negative and Positive Control, Crossover Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib in Healthy Adult Volunteers
Latest Information Update: 04 Oct 2019
At a glance
- Drugs Celecoxib (Primary)
- Indications Acute pain; Ankylosing spondylitis; Back pain; Cervicobrachial syndrome; Dental pain; Dysmenorrhoea; Familial adenomatous polyposis; Juvenile rheumatoid arthritis; Non-small cell lung cancer; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatic disorders; Rheumatoid arthritis; Stomatitis; Tendinitis; Tenosynovitis
- Focus Adverse reactions
Most Recent Events
- 26 Sep 2019 Results assessing the effects of Celecoxib on the QTc Interval, published in the Clinical Therapeutics
- 06 Feb 2019 New trial record